Trial Profile
A Multi-Center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Viral Conjunctivitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2021
Price :
$35
*
At a glance
- Drugs Povidone iodine/dexamethasone (Primary)
- Indications Adenovirus infections; Infectious conjunctivitis
- Focus Therapeutic Use
- Sponsors Foresight Biotherapeutics
- 28 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Jul 2013 Planned wnd date changed from 1 May 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 01 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.